Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
Price:
6.365
USD
-5.98%
Market Closed
Market Cap:
$14.3m
Balance Sheet
Balance Sheet Decomposition
Cyclacel Pharmaceuticals Inc
Cyclacel Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Cyclacel Pharmaceuticals Inc
Cyclacel Pharmaceuticals Inc
Balance Sheet
Cyclacel Pharmaceuticals Inc
Cyclacel Pharmaceuticals Inc
Currency: USD
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
21
|
4
|
2
|
14
|
3
|
20
|
5
|
5
|
3
|
0
|
5
|
4
|
31
|
6
|
20
|
17
|
24
|
18
|
12
|
33
|
37
|
18
|
3
|
3
|
|
| Cash |
0
|
0
|
0
|
0
|
3
|
20
|
5
|
5
|
3
|
0
|
5
|
4
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
21
|
4
|
2
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
0
|
20
|
17
|
24
|
18
|
12
|
33
|
37
|
18
|
3
|
3
|
|
| Short-Term Investments |
0
|
14
|
11
|
33
|
11
|
34
|
53
|
21
|
9
|
29
|
20
|
12
|
0
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
2
|
1
|
2
|
1
|
1
|
4
|
5
|
3
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
21
|
18
|
14
|
48
|
17
|
58
|
64
|
29
|
13
|
31
|
26
|
19
|
35
|
29
|
25
|
20
|
26
|
20
|
14
|
35
|
41
|
24
|
7
|
4
|
|
| PP&E Net |
2
|
3
|
3
|
6
|
2
|
2
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
2
|
3
|
3
|
6
|
2
|
2
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
2
|
3
|
4
|
7
|
9
|
10
|
8
|
9
|
8
|
8
|
8
|
0
|
8
|
8
|
6
|
7
|
6
|
6
|
1
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
3
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
1
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
3
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
25
N/A
|
21
-13%
|
19
-14%
|
56
+201%
|
19
-66%
|
63
+232%
|
76
+20%
|
31
-59%
|
14
-53%
|
31
+117%
|
26
-17%
|
19
-26%
|
36
+84%
|
29
-17%
|
25
-16%
|
20
-21%
|
26
+32%
|
20
-24%
|
15
-23%
|
37
+140%
|
43
+16%
|
28
-35%
|
9
-68%
|
4
-54%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
13
|
2
|
5
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
2
|
3
|
2
|
3
|
1
|
1
|
2
|
3
|
4
|
5
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
2
|
4
|
5
|
6
|
4
|
3
|
4
|
5
|
4
|
4
|
4
|
2
|
2
|
1
|
1
|
1
|
3
|
4
|
4
|
1
|
|
| Short-Term Debt |
0
|
0
|
12
|
3
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
3
|
2
|
1
|
2
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
2
|
2
|
15
|
7
|
15
|
8
|
15
|
9
|
9
|
7
|
7
|
9
|
7
|
7
|
6
|
5
|
4
|
4
|
2
|
2
|
5
|
7
|
8
|
6
|
|
| Long-Term Debt |
1
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
1
|
0
|
1
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
4
+16%
|
16
+318%
|
11
-29%
|
15
+30%
|
9
-37%
|
18
+92%
|
10
-42%
|
9
-17%
|
7
-24%
|
7
-1%
|
9
+44%
|
8
-20%
|
8
+3%
|
6
-23%
|
5
-9%
|
4
-21%
|
5
+7%
|
4
-21%
|
4
-2%
|
5
+50%
|
8
+41%
|
8
+9%
|
6
-24%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
58
|
66
|
67
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
|
| Retained Earnings |
49
|
68
|
87
|
126
|
109
|
138
|
162
|
203
|
222
|
242
|
257
|
270
|
289
|
309
|
323
|
335
|
343
|
350
|
358
|
366
|
385
|
406
|
428
|
439
|
|
| Additional Paid In Capital |
14
|
22
|
25
|
172
|
116
|
195
|
223
|
223
|
228
|
267
|
277
|
280
|
318
|
331
|
343
|
350
|
365
|
366
|
370
|
400
|
423
|
423
|
430
|
438
|
|
| Other Equity |
2
|
2
|
3
|
1
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
21
N/A
|
18
-18%
|
2
-87%
|
44
+1 878%
|
4
-91%
|
54
+1 209%
|
58
+8%
|
21
-64%
|
6
-72%
|
25
+325%
|
20
-22%
|
10
-49%
|
28
+180%
|
22
-23%
|
19
-13%
|
14
-24%
|
22
+53%
|
15
-30%
|
12
-23%
|
33
+184%
|
37
+12%
|
20
-46%
|
1
-97%
|
2
N/A
|
|
| Total Liabilities & Equity |
25
N/A
|
21
-13%
|
19
-14%
|
56
+201%
|
19
-66%
|
63
+232%
|
76
+20%
|
31
-59%
|
14
-53%
|
31
+117%
|
26
-17%
|
19
-26%
|
36
+84%
|
29
-17%
|
25
-16%
|
20
-21%
|
26
+32%
|
20
-24%
|
15
-23%
|
37
+140%
|
43
+16%
|
28
-35%
|
9
-68%
|
4
-54%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
2
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
1
|
1
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
